Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APP
NCT07506369Recruiting
- Sponsor
- Gentofte Hospital
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of Pancreatic polypeptide and pramlintide in obesity (4 arms), sponsored by Gentofte Hospital. Primary endpoint: Food intake. Started Apr 2026; status: recruiting.
02
Drugs
Pancreatic polypeptidepramlintide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07506369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07506369.